{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "binds",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:P62328",
      "entity_text" : "FX",
      "entity_type" : "protein"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uniprot:P26482",
      "entity_text" : "FIXa",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false,
    "context" : {
      "Species" : [ "taxonomy:9606" ]
    }
  },
  "verbose_text" : "XREF_BIBR Emicizumab is a recombinant humanized monoclonal bispecific antibody that binds to and bridges factor IXa (FIXa) and factor X (FX), acting as FVIII-mimetic agent.",
  "reading_complete" : "2020-08-02T13:48:43Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-02T13:47:17Z",
  "trigger" : "binds",
  "evidence" : [ "binds to and bridges factor IXa (FIXa) and factor X (FX" ],
  "pmc_id" : "7373667",
  "score" : 0
}